Loading interface...

Aromasin 25 mg Tablet

Manufactured byPfizer Ltd.
ContainsExemestane
Description
Aromasin 25 mg Tablet is used in the treatment of early stage breast cancer in postmenopausal women and in women who have already been treated with tamoxifen for 2 to 3 years without much clinical response. Patients with vitamin D deficiency are advised to take vitamin D supplements during treatment with this medicine.

Side effects

Major & minor side effects for Aromasin 25 mg Tablet

  • Hypersensitivity
  • Shortness of breath
  • Chest pain
  • Hot flushes
  • Increased sweating
  • Mental depression
  • Bone and joint pain
  • Trouble sleeping
  • Swelling of ankles or feet
  • Difficult or painful urination

Uses of Aromasin 25 mg Tablet

What is it prescribed for?

  • Breast cancer
Read More
Concerns

Commonly asked questions

  • How long does it take for this medicine to take effect?
    The amount of time required for this medicine to show its action is not clinically established.
  • How long do the effects of this medicine last?
    The amount of time for which this medicine remains active in the body is not clinically established.
  • Is it safe to consume alcohol while taking this medicine?
    Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.
  • Is this a habit forming medicine?
    No habit forming tendencies were reported.
  • Can this medicine be taken during pregnancy?
    This medicine is not recommended for use in pregnant women.
  • Can this medicine be taken while breast-feeding?
    This medicine is not recommended for use in breastfeeding women.

Allergy

This medicine is not recommended for use in patients with a known allergy to exemestane or any other components present along with it.
Warnings for special population

Pregnancy

This medicine is not recommended for use in pregnant women.

Breast-feeding

This medicine is not recommended for use in breastfeeding women.
General warnings

Reduction in bone mineral density (BMD)

This medicine may decrease bone mineral density (BMD). The bone mineral density should be assessed prior to initiating the treatment. Routine monitoring of BMD, appropriate corrective measures, or replacement with a suitable alternative may be required based on the clinical condition.

Vitamin D deficiency

Aromasin 25 mg Tablet may cause vitamin D deficiency. The level of 25-hydroxy vitamin D should be assessed prior to initiating the treatment. Routine monitoring of vitamin D levels, appropriate corrective measures, or replacement with a suitable alternative may be required based on the clinical condition.

Co-administration with estrogen containing products

This medicine is not recommended for use along with estrogen containing products since these products may alter the effects of the medicine and vice versa.

Use in premenopausal women

This medicine is not indicated for use in premenopausal women.

Sports

Use of this medicine during sports events is prohibited by World Anti-Doping Agency (WADA).

Missed Dose

Take the missed dose as soon as you remember. If it is almost time for your next dose, skip the missed dose. Do not double your dose to make up for the missed one.

Overdose

Seek emergency medical treatment or contact the doctor in case of an overdose.
All drugs interact differently for person to person. You should check all the possible interactions with your doctor before starting any medicine.
Interaction with Alcohol

Description

Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.

Instructions

Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.
Interaction with Medicine

Carbamazepine

Phenytoin

Bosentan

Thalidomide

Armodafinil

Disease interactions

Disease

Information not available.
Food interactions
Information not available.
Lab interactions
Information not available.
Use Aromasin 25 mg Tablet only for the conditions specified by the doctor. Do not take this medicine in larger or smaller amounts than prescribed or share this medicine with others. Report to the doctor all your medical conditions and current medicines including herbs and supplements before starting treatment with this medicine. Report any undesired effects or lack of improvement to the doctor on priority. Do not stop the use of this medicine without consulting your doctor.
Miscelleneous

To be taken after food

To be taken as instructed by doctor

May cause sleepiness

How it works
Since Aromasin 25 mg Tablet decreases the amount of estrogen in the body, it slows down or stops the growth of certain specific cancer cells which need estrogen to grow.
Legal Status

Approved

Approved

Approved

Approved

Classification

Category

Hormonal antineoplastic agents

Schedule

Schedule H

DailyMed: Exemestane tablet, film coated [Internet]. Dailymed.nlm.nih.gov. 2017 [cited 29 August 2017]. Available from:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=3573e3c9-ca05-413f-909f-93607a2ccb79

Exemestane: MedlinePlus Drug Information [Internet]. Medlineplus.gov. 2017 [cited 29 August 2017]. Available from:

https://medlineplus.gov/druginfo/meds/a607006.html

Exemestane: DrugBank [Internet]. Drugbank.ca. 2017 [cited 29 August 2017]. Available from:

https://www.drugbank.ca/drugs/DB00990

[Internet]. 2017 [cited 29 August 2017]. Available from:

https://www.medicines.org.uk/emc/PIL.9236.latest.pdf

Exemestane [Internet]. Snomedbrowser.com. 2017 [cited 29 August 2017]. Available from:

http://www.snomedbrowser.com/Codes/Details/387017005

What is Prohibited [Internet]. World Anti-Doping Agency. 2017 [cited 29 August 2017]. Available from:

https://www.wada-ama.org/en/prohibited-list/prohibited-at-all-times/hormone-and-metabolic-modulators
Loading related questions...
Something doesn’t feel right?
Report an error

Information on this page was last updated on 15 Sep 2017

Disclaimer

We’ve made all possible efforts to ensure that the information provided here is accurate, up-to-date and complete, however, it should not be treated as a substitute for professional medical advice, diagnosis or treatment. Practo only provides reference source for common information on medicines and does not guarantee its accuracy or exhaustiveness. The absence of a warning for any drug or combination thereof, should not be assumed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Practo does not assume any responsibility for any aspect of healthcare administered with the aid of information provided above. If you have any doubts about your medication then we strongly recommend that you consult with your doctor, nurse or healthcare provider. See detailed T&C here.